Gerald R. Ewoldt

Array ( [id] => 224628 [patent_doc_number] => 07604811 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2009-10-20 [patent_title] => 'Oral-intestinal vaccines against diseases caused by enteropathic organisms using antigens encapsulated within biodegradable-biocompatible microspheres' [patent_app_type] => utility [patent_app_number] => 08/762757 [patent_app_country] => US [patent_app_date] => 1996-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 13980 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/604/07604811.pdf [firstpage_image] =>[orig_patent_app_number] => 08762757 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1098418 [patent_doc_number] => 06818217 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-11-16 [patent_title] => 'Immunoreactive peptides' [patent_app_type] => B1 [patent_app_number] => 08/663272 [patent_app_country] => US [patent_app_date] => 1996-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 5525 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/818/06818217.pdf [firstpage_image] =>[orig_patent_app_number] => 08663272 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 830293 [patent_doc_number] => 07399847 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-07-15 [patent_title] => 'Nucleic acids encoding artificial P-selectin ligands' [patent_app_type] => utility [patent_app_number] => 08/756018 [patent_app_country] => US [patent_app_date] => 1996-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 30 [patent_no_of_words] => 10681 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/399/07399847.pdf [firstpage_image] =>[orig_patent_app_number] => 08756018 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4284354 [patent_doc_number] => 06210913 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-03 [patent_title] => 'Modulation of integrin-mediated signal transduction' [patent_app_type] => 1 [patent_app_number] => 8/734607 [patent_app_country] => US [patent_app_date] => 1996-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 19335 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/210/06210913.pdf [firstpage_image] =>[orig_patent_app_number] => 734607 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4093510 [patent_doc_number] => 06096540 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-01 [patent_title] => 'Differentiation of granulocytic and monocytic progenitor cells' [patent_app_type] => 1 [patent_app_number] => 8/724725 [patent_app_country] => US [patent_app_date] => 1996-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 21 [patent_no_of_words] => 8569 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/096/06096540.pdf [firstpage_image] =>[orig_patent_app_number] => 724725 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1564342 [patent_doc_number] => 06338850 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-15 [patent_title] => 'Methods and products for controlling the immune response of a mammal to glutamic acid decarboxylase' [patent_app_type] => B1 [patent_app_number] => 08/617874 [patent_app_country] => US [patent_app_date] => 1996-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 15 [patent_no_of_words] => 6905 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/338/06338850.pdf [firstpage_image] =>[orig_patent_app_number] => 08617874 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 173740 [patent_doc_number] => 07659119 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-09 [patent_title] => 'Method and compositions for obtaining mature dendritic cells' [patent_app_type] => utility [patent_app_number] => 08/600483 [patent_app_country] => US [patent_app_date] => 1996-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 33 [patent_no_of_words] => 19361 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 179 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/659/07659119.pdf [firstpage_image] =>[orig_patent_app_number] => 08600483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6749896 [patent_doc_number] => 20030044416 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-06 [patent_title] => 'NUCLEIC ACIDS ENCODING CD100 MOLECULES' [patent_app_type] => new [patent_app_number] => 08/556422 [patent_app_country] => US [patent_app_date] => 1995-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 29104 [patent_no_of_claims] => 89 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20030044416.pdf [firstpage_image] =>[orig_patent_app_number] => 08556422 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 890998 [patent_doc_number] => 07344717 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-03-18 [patent_title] => 'Use of erythropoietin in the treatment of rheumatoid arthritis' [patent_app_type] => utility [patent_app_number] => 08/817704 [patent_app_country] => US [patent_app_date] => 1995-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3795 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/344/07344717.pdf [firstpage_image] =>[orig_patent_app_number] => 08817704 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6642748 [patent_doc_number] => 20030103988 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'REGULATION OF ACTIVATED T CELLS BY RECOGNITION OF T CELL RECEPTOR BETA CHAINS AND MAJOR HISTOCOMPATIBILITY COMPLEX CLASS IB MOLECULES' [patent_app_type] => new [patent_app_number] => 08/548595 [patent_app_country] => US [patent_app_date] => 1995-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 18819 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0103/20030103988.pdf [firstpage_image] =>[orig_patent_app_number] => 08548595 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6128393 [patent_doc_number] => 20020076412 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-20 [patent_title] => 'METHODS FOR MODULATING THE IMMUNE SYSTEM' [patent_app_type] => new [patent_app_number] => 08/484409 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6189 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20020076412.pdf [firstpage_image] =>[orig_patent_app_number] => 08484409 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4241148 [patent_doc_number] => 06221352 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-24 [patent_title] => 'Method of preventing the proliferation of V.beta.14 or V.beta.17-Expressing T cells' [patent_app_type] => 1 [patent_app_number] => 8/471209 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 17103 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/221/06221352.pdf [firstpage_image] =>[orig_patent_app_number] => 471209 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1415421 [patent_doc_number] => 06509165 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-21 [patent_title] => 'Detection methods for type I diabetes' [patent_app_type] => B1 [patent_app_number] => 08/472701 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 15735 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/509/06509165.pdf [firstpage_image] =>[orig_patent_app_number] => 08472701 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1520049 [patent_doc_number] => 06413516 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-02 [patent_title] => 'Peptides and methods against psoriasis' [patent_app_type] => B1 [patent_app_number] => 08/182967 [patent_app_country] => US [patent_app_date] => 1994-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10627 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/413/06413516.pdf [firstpage_image] =>[orig_patent_app_number] => 08182967 [rel_patent_id] =>[rel_patent_doc_number] =>)